Pre- and postoperative C-reactive protein levels in patients with cataract and age-related macular degeneration

European Journal of Ophthalmology

Volumn 17, Issue 6, 2007, Pages 919-927

  Zaliuniene, Dalia ^a   Paunksnis, A ^a   Gustiene, O ^a   Brazdzionyte, J ^a   Zaliunas, R ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Age related macular degeneration; Cataract surgery; Contrast sensitivity; High sensitivity C reactive protein

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; CATARACT; CATARACT EXTRACTION; CONTRAST SENSITIVITY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA MACULA AGE RELATED DEGENERATION; VISUAL ACUITY;

EID: 39349085978     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700609     Document Type: Article

References (60)

1. Cimbalas A, Paunksnis A, Cerniauskiene RL, Domarkiene S. [Prevalence and risk factors of age-related maculopathy among middle age people (Lithuanian)]. Medicina (Kaunas) 2003; 39: 1237-43.
2. Jasinskas V, Misevice A, Mankauskiene A. [Tendencies of cataract surgery in Lithuania (Lithuanian)]. Medicina (Kaunas) 2006; 42: 370-6.
3. Taylor HR. Cataract: how much surgery do we have to do? Br J Ophthalmol 2000; 84: 1-2.
4. Laidlaw DA, Harrad RA, Hopper CD, et al. Randomised trial of effectiveness of second eye cataract surgery. Lancet 1998; 352: 925-9.
5. Lundström M, Stenevi U, Thorburn W. Quality of life after first- and second-eye cataract surgery. Five-year data collected by the Swedish National Cataract Register. J Cataract Refract Surg 2001; 27: 1553-9.
6. Tielsch JM, Steinberg EP, Cassard SD, et al. Preoperative functional expectations and postoperative outcomes among patients undergoing first eye cataract surgery. Arch Ophthalmol 1995; 113: 1312-8.
7. Shuttleworth GN, Luhishi EA, Harrad RA. Do patients with age-related maculopathy and cataract benefit from cataract surgery? Br J Ophthalmol 1998; 82: 611-6.
8. Armbrecht AM, Findlay C, Kaushal S, Aspinall P, Hill AR, Dhillon B. Is cataract surgery justified in patients with age-related macular degeneration? A visual function and quality of life assessment. Br J Ophthalmol 2000; 84: 1343-8.
9. Lundstrom M, Brege KG, Floren I, Lundh B, Stenevi U, Thorburn W. Cataract surgery and quality of life in patients with age-related macular degeneration. Br J Ophthalmol 2002; 86: 1330-5.
10. Armbrecht AM, Findlay C, Aspinall PA, Hill AR, Dhillon B. Cataract surgery in patients with age-related macular degeneration: one-year outcomes. J Cataract Refract Surg 2003; 29: 686-93.
11. Schein OD, Steinberg EP, Cassard SD, Tielsch JM, Javitt JC, Sommer A. Predictors of outcome in patients who underwent cataract surgery. Ophthalmology 1995; 102: 817-23.
12. Lundstrom M, Stenevi U, Thorburn W. Outcome of cataract surgery considering the preoperative situation: a study of possible predictors of the functional outcome. Br J Ophthalmol 1999; 83: 1272-6.
13. Desai P, Minassian DC, Reidy A. National cataract surgery survey 1997-8: a report of the results of the clinical outcomes. Br J Ophthalmol 1999; 83: 1336-40.
14. Klein R, Klein BE, Jensen SC, Cruickshanks KJ. The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 1998; 116: 506-13.
15. Pollack A, Bukelman A, Zalish M, Leiba H, Oliver M. The course of age-related macular degeneration following bilateral cataract surgery. Ophthalmic Surg Lasers 1998; 29: 286-94.
16. Klein R, Klein BE, Wong TY, Tomany SC, Cruickshanks KJ. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy. Arch Ophthalmol 2002; 120: 1551-8.
17. Wang JJ, Klein R, Smith W, Klein BE, Tomany S, Mitchell P. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies. Ophthalmology 2003; 110: 1960-7.
18. Freeman EE, Munoz B, West SK, Tielsch JM, Schein OD. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am J Ophthalmol 2003; 135: 849-56.
19. Liu IY, White L, LaCroix AZ. The association of age-related macular degeneration and lens opacities in the aged. Am J Public Health 1989; 79: 765-9.
20. Klein R, Klein BE, Wang Q, Moss SE. Is age-related maculopathy associated with cataracts? Arch Ophthalmol 1994; 112: 191-6.
21. Buch H, Vinding T, la Cour M, Jensen GB, Prause JU, Nielsen NV. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmol Scand 2005; 83: 409-18.
22. Taylor HR, Munoz B, West S, Bressler NM, Bressler SB, Rosenthal FS. Visible light and risk of age-related macular degeneration. Trans Am Ophthalmol Soc 1990; 88: 163-73.
23. Foster CS, Fong LP, Singh G. Cataract surgery and intraocular lens implantation in patients with uveitis. Ophthalmology 1990; 88: 163-73.
24. Hykin PG, Gregson RM, Stevens JD, Hamilton PA. Extracapsular cataract extraction in proliferative diabetic retinopathy. Ophthalmology 1993; 100: 394-9.
25. Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 1998; 96: 557-634.
26. Several TD, Severin SL. Pseudophakic cystoid macular edema: a revised comparison of the incidence with intracapsular and extracapsular cataract extraction. Ophthalmic Surg 1988; 19: 116-8.
27. Kraft MC, Sanders DR, Jampol LM, Lieberman HL. Factors affecting pseudophakic cystoid macular edema: five randomized trials. J Am Intraocul Implant Soc 1985; 11: 380-5.
28. Stark WJ Jr, Maumenee AE, Fagadau W, et al. Cystoid macular edema in pseudophakia. Surv Ophthalmol 1984; 28 Suppl: 442-51.
29. Chambless WS. Phacoemulsification and the retina; cystoid macular edema. Ophthalmology 1979; 86: 2019-22.
30. Moses L. Incidence of cystoid macular edema following cataract extraction with pseudophakos implantation; intracapsular vs. extracapsular vs. phacoemulsification. J Am Intraocul Implant Soc 1978; 4: 17.
31. Nishi O, Nishi K, Imanishi M. Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts. Br J Ophthalmol 1992; 76: 338-41.
32. van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, Pameyer JH, de Jong PT. Increased prevalence of disciform macular degeneration after cataract extraction with implantation of an intraocular lens. Br J Ophthalmol 1994; 78: 441-5.
33. Schaumberg DA, Ridker PM, Glynn RJ, Christen WG, Dana MR, Hennekens CH. High levels of plasma C-reactive protein and future risk of age-related cataract. Ann Epidemiol 1999; 9: 166-71.
34. Klein BE, Klein R, Lee KE, Knudtson MD, Tsai MY. Markers of inflammation, vascular endothelial dysfunction, and age-related cataract. Am J Ophthalmol 2006; 141: 116-22.
35. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004; 291: 704-10.
36. Vine AK, Stader J, Branham K, Musch DC, Swaroop A. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 2005; 112: 2076-80.
37. Ginsburg AP. Contrast sensitivity and functional vision. Int Ophthalmol Clin 2003; 43: 5-16.
38. Chylack LT Jr, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. Arch Ophthalmol 1993; 111: 831-6.
39. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119: 1417-36.
40. Wang JJ, Mitchell P, Smith W, Cumming RG, Attebo K. Impact of visual impairment on use of community support services by elderly persons: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci 1999; 40: 12-9.
41. Midena E, Degli Angeli C, Blarzino MC, Valenti M, Segato T. Macular function impairment in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 1997; 38: 469-77.
42. Alexander MF, Maguire MG, Lietman TM, Snyder JR, Elman MJ, Fine SL. Assessment of visual function in patients with age-related macular degeneration and low visual acuity. Arch Ophthalmol 1988; 106: 1543-7.
43. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
44. Rifai N, Warnick GR. Quality specifications and the assessment of the biochemical risk of atherosclerosis. Clin Chem Acta 2004; 346: 55-64.
45. Olson RJ, Crandall AS. Prospective randomized comparison of phacoemulsification cataract surgery with a 3.2-mm vs a 5.5-mm sutureless incision. Am J Ophthalmol 1998; 125: 612-20.
46. Laurell CG, Zetterstrom C, Philipson B, Syren-Nordqvist S. Randomized study of the blood-aqueous barrier reaction after phacoemulsification and extracapsular cataract extraction. Acta Ophthalmol Scand 1998; 76: 573-8.
47. Dick HB, Schwenn O, Krummenauer F, Krist R, Pfeiffer N. Inflammation after sclerocorneal versus clear corneal tunnel phacoemulsification. Ophthalmology 2000; 107: 241-7.
48. Friedman E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol 2000; 130: 658-63.
49. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004; 122: 598-614.
50. Green WR, Key S. Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc 1977; 75: 180-254.
51. Grindle CFJ, Marshall J. Ageing changes in Bruch's membrane and their functional implications. Trans Ophthalmol Soc UK 1978; 98: 172-5.
52. Penfold P, Killingsworth M, Sarks S. An ultrastructural study of the role of leucocytes and fibroblasts in the breakdown of Bruch's membrane. Aust J Ophthalmol 1984; 12: 23-31.
53. Penfold PL, Provis JM, Billson FA. Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefes Arch Clin Exp Ophthalmol 1987; 225: 70-6.
54. Hageman GS, Luthert PJ, Chong VNH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001; 20: 705-32.
55. Johnson LV, Leitner WP, Staples MK, Anderson DH. Complement activation and inflammatory processes in drusen formation and age-related macular degeneration. Exp Eye Res 2001; 73: 887-96.
56. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002; 134: 411-31.
57. Vine AK, Stader J, Branham K, Musch DC, Swaroop A. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 2005; 112: 2076-80.
58. Klein R, Klein BE, Marino EK, et al. Early age-related maculopathy in the cardiovascular health study. Ophthalmology 2003; 110: 25-33.
59. Danik JS, Chasman DI, Cannon CP. Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia. Ann Hum Genet 2006; 70: 1-12.
60. Khera A, McGuire DK, Murphy SA, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005; 46: 464-9.